Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer

Cancer Immunology, Immunotherapy

Volumn 64, Issue 10, 2015, Pages 1315-1327

  Sersa, Gregor ^a   Teissie, Justin ^b,c   Cemazar, Maja ^a,d   Signori, Emanuela ^e   Kamensek, Urska ^a   Marshall, Guillermo ^f   Miklavcic, Damijan ^g  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF PRIMORSKA   (Slovenia)

^e INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^g UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Abscopal effect; Electrochemotherapy; Electroporation; Gene electrotransfer; PIVAC 14; Vaccination

Indexed keywords

INTERLEUKIN 12; PLASMID DNA; SMALL INTERFERING RNA;

ADJUVANT THERAPY; CANCER CONTROL; CANCER IMMUNIZATION; CELL DEATH; CELL DENSITY; CELL JUNCTION; CELL SIZE; CELL SURFACE; CELL VOLUME; CYTOTOXIC T LYMPHOCYTE; ELECTRIC CONDUCTIVITY; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTROPHORESIS; ELECTROPORATION; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOGENICITY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MEMBRANE PERMEABILITY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET ORGAN; TH1 CELL; ANIMAL; DRUG DELIVERY SYSTEM; GENE TRANSFER; NEOPLASMS; PROCEDURES; VACCINATION;

ANIMALS; DRUG DELIVERY SYSTEMS; ELECTROCHEMOTHERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-12; NEOPLASMS; VACCINATION;

EID: 84940724757     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-015-1724-2     Document Type: Review

References (102)

1. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148. doi:10.1016/j.immuni.2004.07.017
2. Zou WP (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263–274. doi:10.1038/Nrc1586
3. Bruserud O, Ersvaer E, Olsnes A, Gjertsen BT (2008) Anticancer immunotherapy in combination with proapoptotic therapy. Curr Cancer Drug Targets 8:666–675. doi:10.2174/156800908786733496
4. Whelan MC, Casey G, MacConmara M, Lederer JA, Soden D, Collins JK, Tangney M, O’Sullivan GC (2010) Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation. Cancer Gene Ther 17:501–511. doi:10.1038/Cgt.2010.8
5. Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252–264. doi:10.1038/nrc3239
6. Miklavcic D, Mali B, Kos B, Heller R, Sersa G (2014) Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online. doi:10.1186/1475-925x-13-29
7. Spratt DE, Spratt EAG, Wu SH, DeRosa A, Lee NY, Lacouture ME, Barker CA (2014) Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 32:3144–3155. doi:10.1200/Jco.2014.55.4634
8. Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208. doi:10.1038/Nrc3672
9. Postow MA, Callahan MK, Barker CA et al (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366:925–931. doi:10.1056/NEJMoa1112824
10. Heller R, Heller LC (2014) Gene electrotransfer clinical trials. Adv Genet 89:235–262. doi:10.1016/bs.adgen.2014.10.006
11. Daud AI, DeConti RC, Andrews S et al (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903. doi:10.1200/JCO.2007.15.6794
12. Mir LM, Orlowski S (1999) Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 35:107–118. doi:10.1016/S0169-409X(98)00066-0
13. Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D (2014) Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 16:295–320. doi:10.1146/annurev-bioeng-071813-104622
14. Teissie J, Golzio M, Rols MP (2005) Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 1724:270–280. doi:10.1016/j.bbagen.2005.05.006
15. Kotnik T, Kramar P, Pucihar G, Miklavcic D, Tarek M (2012) Cell membrane electroporation-part 1: the phenomenon. IEEE. 28:14–23. doi:10.1109/Mei.2012.6268438
16. Gross D, Loew LM, Webb WW (1986) Optical imaging of cell-membrane potential changes induced by applied electric-fields. Biophys J 50:339–348
17. Hibino M, Shigemori M, Itoh H, Nagayama K, Kinosita K (1991) Membrane conductance of an electroporated cell analyzed by submicrosecond imaging of transmembrane potential. Biophys J 59:209–220. doi:10.1016/S0006-3495(91)82212-3
18. Pucihar G, Krmelj J, Rebersek M, Napotnik TB, Miklavcic D (2011) Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 58:3279–3288. doi:10.1109/TBME.2011.2167232
19. Kotnik T, Pucihar G, Miklavcic D (2010) Induced transmembrane voltage and its correlation with electroporation-mediated molecular transport. J Membr Biol 236(1):3–13. doi:10.1007/s00232-010-9279-9
20. Lopez A, Rols MP, Teissie J (1988) P-31 NMR analysis of membrane phospholipid organization in viable, reversibly electropermeabilized chinese-hamster ovary cells. Biochemistry 27:1222–1228. doi:10.1021/Bi00404a023
21. Golzio M, Mora MP, Raynaud C, Delteil C, Teissie J, Rols MP (1998) Control by osmotic pressure of voltage-induced permeabilization and gene transfer in mammalian cells. Biophys J 74:3015–3022. doi:10.1016/S0006-3495(98)78009-9
22. Chopinet L, Roduit C, Rols MP, Dague E (2013) Destabilization induced by electropermeabilization analyzed by atomic force microscopy. BBA-Biomembranes 1828:2223–2229. doi:10.1016/j.bbamem.2013.05.035
23. Escoffre JM, Bellard E, Faurie C, Sebai SC, Golzio M, Teissie J, Rols MP (2014) Membrane disorder and phospholipid scrambling in electropermeabilized and viable cells. BBA-Biomembranes 1838:1701–1709. doi:10.1016/j.bbamem.2014.02.013
24. Kanthou C, Kranjc S, Sersa G, Tozer G, Zupanic A, Cemazar M (2006) The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther 5:3145–3152. doi:10.1158/1535-7163.MCT-06-0410
25. Meulenberg CJ, Todorovic V, Cemazar M (2012) Differential cellular effects of electroporation and electrochemotherapy in monolayers of human microvascular endothelial cells. PLoS One 7:e52713. doi:10.1371/journal.pone.0052713
26. Lindner P, Neumann E, Rosenheck K (1977) Kinetics of permeability changes induced by electric impulses in chromaffin granules. J Membr Biol 32:231–254
27. Huynh C, Roth D, Ward DM, Kaplan J, Andrews NW (2004) Defective lysosomal exocytosis and plasma membrane repair in Chediak–Higashi/beige cells. Proc Natl Acad Sci USA 101:16795–16800. doi:10.1073/pnas.0405905101
28. Volker TT, Pianet I, Labouesse J, Teissie J (1989) Signal transduction by membrane receptors in viable electropermeabilized cells: isoproterenol-stimulated cyclic AMP synthesis in C6 glioma cells. Biochim Biophys Acta 984:243–251. doi:10.1016/0005-2736(89)90223-X
29. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34:232–240. doi:10.1016/j.ejso.2007.05.016
30. Gabriel B, Teissie J (1994) Generation of reactive-oxygen species induced by electropermeabilization of Chinese hamster ovary cells and their consequence on cell viability. Eur J Biochem 223:25–33. doi:10.1111/j.1432-1033.1994.tb18962.x
31. Pucihar G, Kotnik T, Miklavcic D, Teissie J (2008) Kinetics of transmembrane transport of small molecules into electropermeabilized cells. Biophys J 95:2837–2848. doi:10.1529/biophysj.108.135541
32. Rols MP, Teissie J (1990) Electropermeabilization of mammalian-cells—quantitative-analysis of the phenomenon. Biophys J 58:1089–1098. doi:10.1016/S0006-3495(90)82451-6
33. Paganin-Gioanni A, Bellard E, Escoffre JM, Rols MP, Teissie J, Golzio M (2011) Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells. Proc Natl Acad Sci USA 108:10443–10447. doi:10.1073/pnas.1103519108
34. Breton M, Delemotte L, Silve A, Mir LM, Tarek M (2012) Transport of siRNA through lipid membranes driven by nanosecond electric pulses: an experimental and computational study. J Am Chem Soc 134:13938–13941. doi:10.1021/Ja3052365
35. Golzio M, Teissie J, Rols MP (2002) Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 99:1292–1297. doi:10.1073/pnas.022646499
36. Escoffre JM, Portet T, Favard C, Teissie J, Dean DS, Rols MP (2011) Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. BBA-Biomembranes 1808:1538–1543. doi:10.1016/j.bbamem.2010.10.009
37. Vaughan EE, Dean DA (2006) Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther 13:422–428. doi:10.1016/j.ymthe.2005.10.004
38. Rosazza C, Escoffre JM, Zumbusch A, Rols MP (2011) The actin cytoskeleton has an active role in the electrotransfer of plasmid DNA in mammalian cells. Mol Ther 19:913–921. doi:10.1038/Mt.2010.303
39. Markelc B, Skvarca E, Dolinsek T, Kloboves VP, Coer A, Sersa G, Cemazar M (2015) Inhibitor of endocytosis impairs gene electrotransfer to mouse muscle in vivo. Bioelectrochemistry 103:111–119. doi:10.1016/j.bioelechem.2014.08.020
40. Markelc B, Tevz G, Cemazar M, Kranjc S, Lavrencak J, Zegura B, Teissie J, Sersa G (2012) Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther 19:312–320. doi:10.1038/Gt.2011.97
41. Chin RS, Stuchly MA (2005) Electric fields in bone marrow substructures at power-line frequencies. IEEE Trans Biomed Eng 52:1103–1109. doi:10.1109/Tbme.2005.846712
42. Miklavcic D, Corovic S, Pucihar G, Pavselj N (2006) Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl 4:45–51. doi:10.1016/j.ejcsup.2006.08.006
43. Pavselj N, Miklavcic D (2008) Numerical modeling in electroporation-based biomedical applications. Radiol Oncol 42:159–168. doi:10.2478/v10019-008-0008-2
44. Corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D (2013) Modeling of electric field distribution in tissues during electroporation. Biomed Eng Online 12:16. doi:10.1186/1475-925X-12-16
45. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74:2152–2158. doi:10.1016/S0006-3495(98)77924-X
46. Miklavcic D, Snoj M, Zupanic A et al (2010) Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online. doi:10.1186/1475-925x-9-10
47. Edhemovic I, Gadzijev EM, Brecelj E et al (2011) Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 10:475–485
48. Calvet CY, Thalmensi J, Pliquet E, Liard C, Bestetti T, Demoyen PL, Huet T, Mir LM (2014) Optimization of intradermal gene electrotransfer procedure for human telomerase-based DNA vaccination. Mol Ther 22:S246-S. doi:10.1038/mtm.2014.45
49. Pavselj N, Bregar Z, Cukjati D, Batiuskaite D, Mir LM, Miklavcic D (2005) The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans Biomed Eng 52:1373–1381. doi:10.1109/TBME.2005.851524
50. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D (2010) Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol 236:147–153. doi:10.1007/s00232-010-9274-1
51. Miklavcic D, Semrov D, Mekid H, Mir LM (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73–83. doi:10.1016/S0304-4165(00)00101-X
52. Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D (2005) Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 52:816–827. doi:10.1109/TBME.2005.845212
53. Corovic S, Zupanic A, Kranjc S, Al Sakere B, Leroy-Willig A, Mir LM, Miklavcic D (2010) The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling. Med Biol Eng Comput 48:637–648. doi:10.1007/s11517-010-0614-1
54. Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, Mir LM (2002) Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 5:133–140. doi:10.1006/mthe.2002.0526
55. Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM (2005) Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 16:1194–1201. doi:10.1089/hum.2005.16.1194
56. Calvet CY, Andre FM, Mir LM (2014) Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo Enhanced gene transfer and adjuvant activity. Oncoimmunology 3:e28131. doi:10.4161/onci.28540
57. Andre FM, Gehl J, Sersa G et al (2008) Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 19:1261–1271. doi:10.1089/Hum.2008.060
58. Cemazar M, Golzio M, Sersa G, Hojman P, Kranjc S, Mesojednik S, Rols MP, Teissie J (2009) Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Ther 16:635–644. doi:10.1038/gt.2009.10
59. Guo SQ, Donate A, Basu G, Lundberg C, Heller L, Heller R (2011) Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 151:256–262. doi:10.1016/j.jconrel.2011.01.014
60. Ferraro B, Cruz YL, Coppola D, Heller R (2009) Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 17:651–657. doi:10.1038/Mt.2009.12
61. Marie C, Vandermeulen G, Quiviger M, Richard M, Preat V, Scherman D (2010) pFARs, plasmids free of antibiotic resistance markers, display high-level transgene expression in muscle, skin and tumour cells. J Gene Med 12(4):323–332. doi:10.1002/jgm.1441
62. Zupanic A, Kos B, Miklavcic D (2012) Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation. Phys Med Biol 57:5425–5440. doi:10.1088/0031-9155/57/17/5425
63. Peng B, Zhao Y, Xu L, Xu Y (2007) Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine 25:2064–2073. doi:10.1016/j.vaccine.2006.11.042
64. Lackovic I, Magjarevic R, Miklavcic D (2009) Three-dimensional finite-element analysis of joule heating in electrochemotherapy and in vivo gene electrotransfer. IEEE 16:1338–1347. doi:10.1109/TDEI.2009.5293947
65. Olaiz N, Signori E, Maglietti F, Soba A, Suarez C, Turjanski P, Michinski S, Marshall G (2014) Tissue damage modeling in gene electrotransfer: the role of pH. Bioelectrochemistry 100:105–111. doi:10.1016/j.bioelechem.2014.05.001
66. Calvet CY, Famin D, Andre FM, Mir LM (2014) Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 3:e28131. doi:10.4161/onci.28131
67. Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D (2013) Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 39:4–16. doi:10.1016/j.ejso.2012.08.016
68. Cemazar M, Miklavcic D, Scancar J, Dolzan V, Golouh R, Sersa G (1999) Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79:1386–1391. doi:10.1038/sj.bjc.6690222
69. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr, Kourilsky P (1995) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphas Tumor Immunol 17:30–38
70. Gerlini G, Sestini S, Di Gennaro P, Urso C, Pimpinelli N, Borgognoni L (2013) Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 30(1):37–45. doi:10.1007/s10585-012-9505-1
71. Sersa G, Cemazar M, Menart V, Gaberc-Porekar V, Miklavcic D (1997) Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett 116:85–92. doi:10.1016/S0304-3835(97)00170-5
72. Sersa G, Miklavcic D, Cemazar M, Belehradek J, Jarm T, Mir LM (1997) Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem Bioenerg 43:279–283. doi:10.1016/S0302-4598(96)05194-X
73. Frey B, Rubner Y, Wunderlich R, Weiss EM, Pockley AG, Fietkau R, Gaipl US (2012) Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation—implications for cancer therapies. Curr Med Chem 19:1751–1764. doi:10.2174/092986712800099811
74. Cemazar M, Todorovic V, Scancar J, Lampreht U, Stimac M, Kamensek U, Kranjc S, Coer A, Sersa G (2015) Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness. Radiol Oncol 49(1):32–40. doi:10.1515/raon-2015-0005
75. Sersa G, Kotnik V, Cemazar M, Miklavcic D, Kotnik A (1996) Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice—natural resistance and immune responsiveness. Anticancer Drugs 7:785–791. doi:10.1097/00001813-199609000-00011
76. Todorovic V, Sersa G, Mlakar V, Glavac D, Flisar K, Cemazar M (2011) Metastatic potential of melanoma cells is not affected by electrochemotherapy. Melanoma Res 21:196–205. doi:10.1097/CMR.0b013e328337abd7
77. Ramirez LH, Orlowski S, An D et al (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77:2104–2111
78. Sedlar A, Dolinsek T, Markelc B, Prosen L, Kranjc S, Bosnjak M, Blagus T, Cemazar M, Sersa G (2012) Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 46:302–311. doi:10.2478/v10019-012-0044-9
79. Sersa G, Cemazar M, Miklavcic D, Mir LM (1994) Electrochemotherapy—variable antitumor effect on different tumor-models. Bioelectrochem Bioenerg 35:23–27. doi:10.1016/0302-4598(94)87006-3
80. Cemazar M, Miklavcic D, Sersa G (1998) Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res 89:328–333
81. Stevenson FK, Ottensmeier CH, Rice J (2010) DNA vaccines against cancer come of age. Curr Opin Immunol 22:264–270. doi:10.1016/j.coi.2010.01.019
82. Sioud M (2015) RNA interference: mechanisms, technical challenges, and therapeutic opportunities. Methods Mol Biol 1218:1–15. doi:10.1007/978-1-4939-1538-5_1
83. Scheerlinck JP, Karlis J, Tjelle TE, Presidente PJ, Mathiesen I, Newton SE (2004) In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22:1820–1825. doi:10.1016/j.vaccine.2003.09.053
84. Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, Signori E (2008) Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 8:1645–1657. doi:10.1517/14712598.8.11.1645
85. Cemazar M, Sersa G (2007) Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther 9:554–562
86. Heller LC, Heller R (2010) Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 10:312–317. doi:10.2174/156652310791823489
87. Cemazar M, Jarm T, Sersa G (2010) Cancer electrogene therapy with interleukin-12. Curr Gene Ther 10:300–311
88. Glikin GC, Finocchiaro LM (2014) Clinical trials of immunogene therapy for spontaneous tumors in companion animals. Sci World J 2014:718520. doi:10.1155/2014/718520
89. Lucas ML, Heller R (2003) IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 22(12):755–763. doi:10.1089/104454903322624966
90. Pavlin D, Cemazar M, Kamensek U, Tozon N, Pogacnik A, Sersa G (2009) Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma. Cancer Biol Ther 8(22):2114–2122. doi:10.2478/v10019-010-0041-9
91. Sedlar A, Kranjc S, Dolinsek T, Cemazar M, Coer A, Sersa G (2013) Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma. BMC Cancer 13:38. doi:10.1186/1471-2407-13-38
92. Tevz G, Kranjc S, Cemazar M, Kamensek U, Coer A, Krzan M, Vidic S, Pavlin D, Sersa G (2009) Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. J Gene Med 11:1125–1137. doi:10.1002/Jgm.1403
93. Kamensek U, Sersa G, Cemazar M (2013) Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model. Mol Cancer 12(1):136. doi:10.1186/1476-4598-12-136
94. Kishida T, Asada H, Itokawa Y, Yasutomi K, Shin-Ya M, Gojo S, Cui FD, Ueda Y, Yamagishi H, Imanishi J, Mazda O (2003) Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 8(5):738–745. doi:10.1016/j.ymthe.2003.08.002
95. Torrero MN, Henk WG, Li S (2006) Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res 12(1):257–263. doi:10.1158/1078-0432.CCR-05-1514
96. Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R (2000) In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res 10(6):577–583
97. Shirley SA, Lundberg CG, Li F, Burcus N, Heller R (2015) Controlled gene delivery can enhance therapeutic outcome for cancer immune therapy for melanoma. Curr Gene Ther 15(1):32–43. doi:10.2174/1566523214666141121111630
98. Quaglino P, Osella-Abate S, Marenco F, Nardo T, Gado C, Novelli M, Savoia P, Bernengo MG (2011) FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. Pigment Cell Melanoma Res. 24:734–736. doi:10.1111/j.1755-148X.2011.00879.x
99. Forde PF, Sadadcharam M, Hall LJ, O’Donovan TR, de Kruijf M, Byrne WL, O’Sullivan GC, Soden DM (2014) Enhancement of electroporation facilitated immunogene therapy via T-reg depletion. Cancer Gene Ther 21:349–354. doi:10.1038/Cgt.2014.35
100. Zheng Y, Dou Y, Duan L, Cong C, Gao A, Lai Q, Sun Y (2015) Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer. Cell Immunol 294(1):54–59. doi:10.1016/j.cellimm.2015.02.003Epub 2015 Feb 10
101. Goc J, Fridman WH, Sautes-Fridman C, Dieu-Nosjean MC (2013) Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology 2:e26836. doi:10.4161/onci.26836
102. Pucihar G, Kotnik T, Valic B, Miklavcic D (2006) Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng 34:642–652. doi:10.1007/s10439-005-9076-2